SGMT · Sagimet Biosciences Inc
United States · RS rating 92 · As of 2026-11-03
| Price | 9.95 USD |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 82 / 86 / 65 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 52 / 54 / 70 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +27.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +10.9% |
| Market cap (USD) | $191.3M |